openPR Logo
Press release

AI-empowered interventional robotics firm, NDR Medical expands into Japan with Real Tech Global Fund

05-21-2021 09:14 AM CET | Health & Medicine

Press release from: NDR Medical Technology

ANT-X, Fluoroscopy-guided needle targeting robot

ANT-X, Fluoroscopy-guided needle targeting robot

NDR Medical Technology, a Singapore-based company with the world's first AI-empowered interventional robotic systems has tapped on The Real Tech Global Fund to lay the ground for its expansion into the attractive Japanese medical device market.

NDR aims to launch its ANT system in Japan by 2022. With the world’s fastest aging population of 126 million, Japan, the 2nd biggest medical device market after the US is set to reach from $54.5 billion in 2018 to $74.7 billion in 2025, growing at a compound annual growth rate (CAGR) of 4.6%. NDR collaborated with Nagoya City University Graduate School of Medicine (Department of Nephrology and Urology) has completed two clinical trials. Leveraging on these successful trials, the company aims to develop Japan into one of their key markets together with the US and China. Real Tech Holdings Co., Ltd. was incorporated as a strategic partner to accelerate their collaboration with healthcare institutions, distributors, and business corporations in Japan.

NDR’s ANT System transforms the way clinicians perform their interventional procedures by allowing them to accurately and quickly assess a patient’s anatomy and insert the needle precisely and safely. The core technology is based on the lightweight robot specifically designed for the medical field and AI that transforms real-time image analyses into precise robotic movements. For global expansion, NDR has obtained CE certification and filed for FDA approval. In 2021, NDR signed a JV agreement with China’s MicroPort for the commercialization of the ANT system in China. Moving forward, with Japan being a huge market, NDR will be commencing efforts to obtain Japan PMDA regulatory approval in preparation for product commercialization.

NDR Medical Technology Pte. Ltd.
75 Ayer Rajah Crescent, Singapore (139953)
Jay Lee
jaylee@ndrmedical.com

NDR Medical Technology Pte. Ltd.
Date of Establishment: 14th of October 2014
Location: 75 Ayer Rajah Crescent, Singapore (139953)
CEO : Mr. Alan Goh
Business Activities: Development & production of AI-empowered interventional robotic system
website: https://ndrmedical.com/

REAL TECH FUND
REAL TECH FUND is a venture capital fund managed by Real Tech Holdings and its subsidiary of Real Tech Japan. It solely invests in deep-tech startups solving societal and environmental issues.
Formal name: Real Tech Fund 1 Investment Limited Partnership (A), Real Tech Fund 2 Investment Limited Partnership (A), Real Tech Fund 3 Investment Limited Partnership (A), Real Tech Global Fund 1 Investment Business Partnership (B)
General Partner: (A) Real Tech Japan L.L.C
Operating Partner: (B) Real Tech Holdings Co.,Ltd.
For more information: https://www.realtech.fund

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release AI-empowered interventional robotics firm, NDR Medical expands into Japan with Real Tech Global Fund here

News-ID: 2287955 • Views: 1199